Matches in Wikidata for { <http://www.wikidata.org/entity/Q92756955> ?p ?o ?g. }
- Q92756955 description "article scientifique publié en 2019" @default.
- Q92756955 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92756955 description "scientific article published on 14 June 2019" @default.
- Q92756955 description "wetenschappelijk artikel" @default.
- Q92756955 description "наукова стаття, опублікована 14 червня 2019" @default.
- Q92756955 name "Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial" @default.
- Q92756955 name "Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial" @default.
- Q92756955 type Item @default.
- Q92756955 label "Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial" @default.
- Q92756955 label "Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial" @default.
- Q92756955 prefLabel "Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial" @default.
- Q92756955 prefLabel "Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial" @default.
- Q92756955 P1433 Q92756955-F0AA2B81-05CD-4439-9ADE-11E23B25F540 @default.
- Q92756955 P1476 Q92756955-64B8B18F-421D-4C01-819A-A2254469BE16 @default.
- Q92756955 P2093 Q92756955-0F11CDE0-2A78-45D8-A17D-E033DDB53290 @default.
- Q92756955 P2093 Q92756955-1B418BF6-4E45-4163-BDE7-8E113186D4D3 @default.
- Q92756955 P2093 Q92756955-2EE44A21-467C-460B-89A2-FE3845AC2361 @default.
- Q92756955 P2093 Q92756955-3F0882F5-1DED-46CA-AA05-B1541715AE0C @default.
- Q92756955 P2093 Q92756955-4499A8E4-0AA9-45CA-A4A5-7DF1B4888F82 @default.
- Q92756955 P2093 Q92756955-BE076ACC-7093-4494-86E0-42B9F691568E @default.
- Q92756955 P2093 Q92756955-C1F67DF9-6ECC-42B7-A242-4CB1E76FEB16 @default.
- Q92756955 P2093 Q92756955-EC1B7C7C-C78D-4B01-B875-18355990C465 @default.
- Q92756955 P2093 Q92756955-F72BCAB6-7EF0-4FFA-8DEB-48B27062E138 @default.
- Q92756955 P2093 Q92756955-FF229F89-747F-4B20-BA3A-894322606EE7 @default.
- Q92756955 P2860 Q92756955-0EA7F0AF-4CA3-4C1E-909A-F269A03AD991 @default.
- Q92756955 P2860 Q92756955-0F9F505B-CCE5-4A81-AA07-DDE3B6CF04B2 @default.
- Q92756955 P2860 Q92756955-1B655EED-6354-477A-8ABF-889510CB3080 @default.
- Q92756955 P2860 Q92756955-1D59477F-9A23-4515-8701-2F543D28A4D1 @default.
- Q92756955 P2860 Q92756955-334F3475-8D80-46A5-A75A-C64C17E0CA0F @default.
- Q92756955 P2860 Q92756955-3FE5FB26-05F6-4144-B432-35F38FD80964 @default.
- Q92756955 P2860 Q92756955-475D853B-F9ED-4F68-9F1F-73FB22D9E467 @default.
- Q92756955 P2860 Q92756955-57B958E5-A620-4879-9DCD-FDF77714B84F @default.
- Q92756955 P2860 Q92756955-5C5900FD-B117-42DC-AF1F-AF38A6537844 @default.
- Q92756955 P2860 Q92756955-8E5AF096-E281-4E5C-9A9E-4D406A7269E0 @default.
- Q92756955 P2860 Q92756955-90F6C82F-2C69-495A-B192-EDF052695A8A @default.
- Q92756955 P2860 Q92756955-92C36BFE-F019-4B59-8EE2-17B29D790BA0 @default.
- Q92756955 P2860 Q92756955-9627AF05-D176-4242-9A81-EA5BDFBD4757 @default.
- Q92756955 P2860 Q92756955-A6C3BBB3-2721-464D-B9F9-569094F94381 @default.
- Q92756955 P2860 Q92756955-AE507D44-EAC0-4C7F-ACFF-15F9899A2444 @default.
- Q92756955 P2860 Q92756955-B0A5B5A2-2C34-466D-8BFA-2C7469B0007F @default.
- Q92756955 P2860 Q92756955-B12244EF-8B74-40AE-8514-21998FC3761A @default.
- Q92756955 P2860 Q92756955-B68E04AE-2CA3-4A45-AABC-7AA2EEE4EA7C @default.
- Q92756955 P2860 Q92756955-BB1A90A9-0906-4666-B3E9-4BD4313D5C31 @default.
- Q92756955 P2860 Q92756955-BC9E829A-40EA-415F-B2B8-3CBDEE526145 @default.
- Q92756955 P2860 Q92756955-CCF8088B-4FC6-4EF4-937A-4FD18A493DC8 @default.
- Q92756955 P2860 Q92756955-CD615728-A30E-461F-A30C-4913784C2B4B @default.
- Q92756955 P2860 Q92756955-D01A8DA9-2BD0-4DDD-986C-8ABCF4B652B7 @default.
- Q92756955 P2860 Q92756955-EEE9676C-AE66-4F05-8968-0803A9AA2F2D @default.
- Q92756955 P2860 Q92756955-F62D50EF-5CB3-4180-B94A-3828517CF26F @default.
- Q92756955 P2860 Q92756955-FE7331F8-AD6F-4C09-85BF-A51AD8423342 @default.
- Q92756955 P304 Q92756955-47A0720E-AFD6-46C3-83B3-E2EA218353BB @default.
- Q92756955 P31 Q92756955-6C7E2694-BF53-48A0-9875-670BCA951AA7 @default.
- Q92756955 P356 Q92756955-2890E203-7995-4468-855A-0735A6E6F5E1 @default.
- Q92756955 P433 Q92756955-D275DC5F-3764-40B8-A015-E63CF9D7D9CD @default.
- Q92756955 P478 Q92756955-55C1CF76-8BA9-49C8-B2DA-6EED5E8AB0CC @default.
- Q92756955 P50 Q92756955-3483914D-B393-4322-92BF-A0803FA566C9 @default.
- Q92756955 P50 Q92756955-61C01BD0-A4E4-4B87-9018-07C5B5952B0E @default.
- Q92756955 P577 Q92756955-8CB12705-F0A1-4FA1-AD40-31618C2BA9A0 @default.
- Q92756955 P698 Q92756955-E65352D8-C60C-432B-B424-99EF8BDD6508 @default.
- Q92756955 P921 Q92756955-3D567CC9-B2F7-4B4D-85DA-B3E259288710 @default.
- Q92756955 P921 Q92756955-6E904784-E709-430A-93C0-A2F268068FCE @default.
- Q92756955 P921 Q92756955-A5859E7C-C5B1-43D9-9524-24810C30B690 @default.
- Q92756955 P932 Q92756955-C3B23118-CC89-4762-8825-FF6F12A743E1 @default.
- Q92756955 P356 S12885-019-5541-4 @default.
- Q92756955 P698 31200667 @default.
- Q92756955 P1433 Q326300 @default.
- Q92756955 P1476 "Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial" @default.
- Q92756955 P2093 "Andrew Hall" @default.
- Q92756955 P2093 "David Gonzalez de Castro" @default.
- Q92756955 P2093 "Hannah L Buckley" @default.
- Q92756955 P2093 "Jonathan Wadsley" @default.
- Q92756955 P2093 "Kate Farnell" @default.
- Q92756955 P2093 "Kate Newbold" @default.
- Q92756955 P2093 "Laura Moss" @default.
- Q92756955 P2093 "Louise Flanagan" @default.
- Q92756955 P2093 "Sarah R Brown" @default.
- Q92756955 P2093 "Yong Du" @default.
- Q92756955 P2860 Q24596266 @default.
- Q92756955 P2860 Q24802587 @default.
- Q92756955 P2860 Q27851971 @default.
- Q92756955 P2860 Q27853021 @default.
- Q92756955 P2860 Q27853180 @default.
- Q92756955 P2860 Q30384829 @default.
- Q92756955 P2860 Q33995708 @default.
- Q92756955 P2860 Q34633455 @default.
- Q92756955 P2860 Q34652628 @default.
- Q92756955 P2860 Q35195766 @default.
- Q92756955 P2860 Q35677661 @default.
- Q92756955 P2860 Q36295237 @default.
- Q92756955 P2860 Q37505185 @default.
- Q92756955 P2860 Q37598084 @default.
- Q92756955 P2860 Q38072250 @default.
- Q92756955 P2860 Q40277844 @default.
- Q92756955 P2860 Q44963166 @default.
- Q92756955 P2860 Q50597206 @default.
- Q92756955 P2860 Q53569559 @default.
- Q92756955 P2860 Q54375138 @default.
- Q92756955 P2860 Q54588857 @default.
- Q92756955 P2860 Q55067769 @default.
- Q92756955 P2860 Q56554243 @default.